Positive tests for serum anti-endomisium antibodies (AEA) and anti-jejunal antibodies (JAB) and histopathological diagnosis of celiac disease in children

Ustav patológie FN Nitra, Slovenská republika.
Vnitr̆ní lékar̆ství 02/2008; 54(1):25-30.
Source: PubMed


Non-invasive examination methods are increasingly important in diagnosing celiac disease. New options for diagnosing celiac disease have been discovered in addition to the established biochemical, hematological and other methods as a result expansive progress ofclinical genetics and immunology. At the same time, detection of circulating auto-antibodies is becoming ever more frequent in clinical practice. As a result, many new, clinically highly heterogeneous cases of the disease have been diagnosed and consequently the prevalence of the disease in both child and adult population has grown. Detection of anti-endomysial antibodies (AEA), characteristic for their high sensitivity and specificity, plays an important role in diagnosing and monitoring celiac disease in pediatric practice. Nevertheless, histopathological diagnosis remains the critical tool for definitive diagnosis of the disease. The article refers to relations between the degree of positivity of AEA and JAB antibodies in the IgA class and the respective grade in the Marsh grading system. The objective of the study was to examine AEA and JAB antibodies and the histological picture of the duodenal mucosa in 20 children and adolescents with celiac disease aged from 2 to 18 years. The authors developed a semiquantitative scale of positivity of both the antibodies, which they compared trying to find a correlation between these and the histopathological picture of the duodenal mucosa. The authors point out the need of timely determination of AEA and t-TG (tissue transglutaminase) in patients whose anamnesis, clinical picture or laboratory results may be indicative of celiac disease.

Download full-text


Available from: Pavol Makovicky, Jan 30, 2015
2 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Celiac disease is a lifelong autoimmune intestinal disorder caused by sensitivity to gluten. In clinical practice, no causal treatment is currently available and the disease can only be treated by strict adherence to a gluten-free diet. The disease that was known in ancient Greece continues to draw attention of the professional public worldwide and has been studied by many researchers. As a result, a range of theoretical and practical knowledge has been obtained and thus further aspects of the disease can be addressed. At present the discussion is open not only to doctors, pharmacists, scientists and researchers at various posts, but also to economists, lawyers and managers. In the spectrum of disease manifestations, some new forms were diagnosed, including associations with other diseases. Therefore, a higher prevalence of this disease has been reported. Multiple review articles appeared in both the local and international literature to familiarize the professional public with the symptoms and signs of the disease. Their common aim was to contribute to the detection of the disease in children and adults. Despite that, the disease remains underdiagnosed. In this context, new challenges emerge in the field of celiac disease. The current practice in diagnosing celiac disease and the available and candidate dietary interventions for effective protection and support therapy are described. The importance of early screening and advanced approaches to disease management is underlined.
    Epidemiologie, mikrobiologie, imunologie: casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne 09/2008; 57(3):90-6. · 0.35 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Celiac disease is diagnosed in children as well as adults. For long now, this has not been a rare diagnosis. Publications by local authors have warned, as early as 1990s, that this disease is extremely under-diagnosed, as confirmed by current clinical practice. Despite this, it is evident that the prevalence ofthis disease in Slovakia and the Czech Republic is high. Currently, it is assumed that the traditional symptomatic form of the disease represents just a fraction of the overall prevalence. As a consequence to the gradual introduction of the disease screening and the efforts of the medical community to diagnose the disease in its early stages, the disease is now thought of in a surgery of a first-contact physician as well as in a specialist surgery. Continually increasing number of diagnosed patients leads to increasing demands related to their needs. Strict gluten-free diet is the only available causal therapy. Gluten-free products are marked with a universally recognised international symbol--crossed-out grain spike--or are labelled "gluten-free". Some specialized family-run businesses focusing on their production have all foodstuffs labelled. However, this labelling is rather lacking on the products sold in high street stores. Based on the increasing incidence of celiac disease in the population, or rather improved diagnostic methods and increased awareness within the medical community of this diagnosis, the authors review the possibility of labelling all food products. This would be a universally recognised symbol, or a clear warning that the product contains gluten. It is recommended that a proposal is submitted to improve legislation related to labelling of gluten-containing products. It is recommended that the products labelled as "gluten-free" contain no gluten. It is proposed that the production of gluten-free food products is submitted to accreditation with well-defined methodology including strict control.
    Vnitr̆ní lékar̆ství 07/2009; 55(6):583-6.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Even though guidelines for diagnosing celiac disease have been compiled and accepted by a number of expert associations, this disease continues to be under-diagnosed in children and, particularly, in adults. This is even though numerous scientific papers, short case studies and review papers have been published highlighting this issue and consensually supporting screening methods. In addition, research results by reputable Czech and Slovak authors suggest that, at present, only a small proportion of all cases of celiac disease are correctly diagnosed. Considering this, methods to diagnose the disease in its initial stage are continuously being sought. Biopsy of the mucosa of the small intestine remains the gold standard when diagnosing celiac disease. Within the targeted diagnostic algorithm, less invasive techniques should precede biopsy. These are applied mainly in cases of atypical forms of the disease and are based on an examination of serum autoantibodies. Their application and use is advantageous from many perspectives. However, practical clinical experience showed that they are not always sufficiently specific and sensitive. Using their own experience and published literature, the authors discuss the issues of screening and diagnosing celiac disease. It is obvious that targeted screening will undoubtedly uncover new, mainly atypical forms of celiac disease, while some cases shall remain undiagnosed. The diagnosis of celiac disease can be made on the basis of clinical, laboratory and histopathological correlation, respecting possible difficulties.
    Vnitr̆ní lékar̆ství 02/2011; 57(2):183-7.